Identification of the Binding Site of Apical Membrane Antigen 1 (AMA1) Inhibitors Using a Paramagnetic Probe.


Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
05 03 2019
Historique:
received: 17 12 2018
pubmed: 18 1 2019
medline: 17 1 2020
entrez: 18 1 2019
Statut: ppublish

Résumé

Apical membrane antigen 1 (AMA1) is essential for the invasion of host cells by malaria parasites. Several small-molecule ligands have been shown to bind to a conserved hydrophobic cleft in Plasmodium falciparum AMA1. However, a lack of detailed structural information on the binding pose of these molecules has hindered their further optimisation as inhibitors. We have developed a spin-labelled peptide based on RON2, the native binding partner of AMA1, to probe the binding sites of compounds on PfAMA1. The crystal structure of this peptide bound to PfAMA1 shows that it binds at one end of the hydrophobic groove, leaving much of the binding site unoccupied and allowing fragment hits to bind without interference. In paramagnetic relaxation enhancement (PRE)-based NMR screening, the

Identifiants

pubmed: 30653832
doi: 10.1002/cmdc.201800802
doi:

Substances chimiques

Antigens, Protozoan 0
Benzimidazoles 0
Furans 0
Ligands 0
Membrane Proteins 0
Molecular Probes 0
Peptides 0
Protozoan Proteins 0
Pyrazoles 0
Pyrimidines 0
Pyrroles 0
Quinazolinones 0
Sulfonamides 0
apical membrane antigen I, Plasmodium 0
pyrrolopyrimidine 0
pyrazole 3QD5KJZ7ZJ
benzimidazole E24GX49LD8
furan UC0XV6A8N9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

603-612

Informations de copyright

© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Auteurs

Mansura Akter (M)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia.

Nyssa Drinkwater (N)

Biomedicine Discovery Institute, Department of Microbiology, Monash University, Wellington Road, Clayton, Victoria, 3800, Australia.

Shane M Devine (SM)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia.

Simon C Drew (SC)

Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Melbourne, Victoria, 3010, Australia.

Bankala Krishnarjuna (B)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia.

Cael O Debono (CO)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia.

Geqing Wang (G)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia.

Martin J Scanlon (MJ)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia.

Peter J Scammells (PJ)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia.

Sheena McGowan (S)

Biomedicine Discovery Institute, Department of Microbiology, Monash University, Wellington Road, Clayton, Victoria, 3800, Australia.

Christopher A MacRaild (CA)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia.

Raymond S Norton (RS)

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia.

Articles similaires

Animals Hemiptera Insect Proteins Phylogeny Insecticides
alpha-Synuclein Humans Animals Mice Lewy Body Disease
Adenosine Triphosphate Adenosine Diphosphate Mitochondrial ADP, ATP Translocases Binding Sites Mitochondria
Eimeria tenella Animals Antigens, Protozoan Chickens Genetic Variation

Classifications MeSH